自拍无码精品一区二区|亚洲А∨天堂久久精品|国产日韩欧美一区二区视|亚洲av高清dvd丝袜|中文一级无码黄片精品视频|亚洲无码网站在线免费观看|免费无码又爽又刺激又污又黄|成人免费无码婬片在线观看免费

  • <tfoot id="icskm"></tfoot>
  • <code id="icskm"><xmp id="icskm"></xmp></code>
  • <li id="icskm"><input id="icskm"></input></li>
    <code id="icskm"></code>
  • <cite id="icskm"><center id="icskm"></center></cite><button id="icskm"><bdo id="icskm"></bdo></button><code id="icskm"></code>
  • <cite id="icskm"><pre id="icskm"></pre></cite>
    <button id="icskm"></button>
  • <rt id="icskm"><pre id="icskm"></pre></rt>
    <cite id="icskm"></cite>
    <li id="icskm"></li>
    <button id="icskm"><input id="icskm"></input></button>
  • 159-2642-3062 027-65317797
    服務(wù)熱線(工作日:9:00-17:30)

    瀏覽量: 275

    • 產(chǎn)品名稱: Research Grade Canakinumab ( 卡那奴單抗 )
    • 產(chǎn)品貨號: CSD00155
    • 貨期: 現(xiàn)貨
    • 價格與訂購: 2480
    • 數(shù)量:
      庫存: 100
    • 規(guī)格: 100μg
    • 產(chǎn)品信息
    • 如何訂購
      貨號(Catalog No.)
      CSD00155
      通用名INN
      Canakinumab
      純度(Purity)
      >95%
      濃度( Concentration)
      1mg/ml
      Formulation
      PBS buffer PH7.5
      Source
      CHO cells
      內(nèi)毒素(Endotoxin level)
      Please contact with the lab for this information.
      產(chǎn)品描述(Description)
      Canakinumab is a recombinant, human anti-human-IL-1β monoclonal antibody that belongs to the IgG1/κ isotype subclass. It is expressed in a murine Sp2/0-Ag14 cell line and comprised of two 447- (or 448-) residue heavy chains and two 214-residue light chains, with a molecular mass of 145157 Daltons when deglycosylated. Both heavy chains of canakinumab contain oligosaccharide chains linked to the protein backbone at asparagine 298 (Asn 298). Canakinumab binds to human IL-1β and neutralizes its inflammatory activity by blocking its interaction with IL-1 receptors, but it does not bind IL-1alpha or IL-1 receptor antagonist (IL-1ra). Canakinumab is marketed under the brand name Ilaris and indicated for patients 4 years of age and older to treat Familial Cold Autoinflammatory Syndrome (FCAS) and Muckle-Wells Syndrome (MWS), which are both part of the Cryopyrin-Associated Periodic Syndromes (CAPS) as well as for patients 2 years of age and older to treat systemic juvenile idiopathic arthritis (SJIA). Clinical trials have established the administration of canakinumab every 2 weeks to be safe and effective, offering a considerable advantage over the existing treatment with the human IL-1 receptor antagonist, anakinra, which must be injected daily and which is often poorly tolerated by patients.
      別名(Alternative names)
      ACZ885
      靶點;物種(Specificity target name;species)
      IL1B[Homo sapiens]
      種類(Species)
      Homo sapiens
      受體鑒定(Receptor identification)
      IgG1-kappa
      分子量(MV)
      145200.00 Da
      CAS
      914613-48-2
      存儲條件(Storage)
      Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
      Store at +4°C short term (1-2 weeks).
      Store at -20 °C 12 months.
      Store at -80°C long term.
      受體鑒定(Receptor identification)
      Note
      For research use only .
    洞头县| 高青县| 安吉县| 绥化市| 兴隆县| 阳泉市| 呼伦贝尔市| 嘉善县| 临海市| 侯马市| 清远市| 宜君县| 汽车| 葵青区| 秦皇岛市| 永昌县| 抚顺县| 宽甸| 阿荣旗| 蓝田县| 辽源市| 大名县| 白河县| 东乡| 全州县| 丹凤县| 郴州市| 鄂州市| 阿巴嘎旗| 清徐县| 滕州市| 曲麻莱县| 鄂托克旗| 庆城县| 奇台县| 渑池县| 垫江县| 平定县| 长宁区| 仪征市| 静安区|